Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Abdominal Aortic Aneurysms Screening Urged in Seniors

By HospiMedica International staff writers
Posted on 31 Aug 2015
Two-thirds of deaths due to abdominal aortic aneurysm (AAA) rupture occur in people aged 75 and older and screening strategies should be updated to reflect the demographic shift, claims a new study. More...


Researchers at John Radcliffe Hospital (Oxford, United Kingdom) and Oxford University (United Kingdom) conducted a prospective, population‐based study to determine the incidence and outcome of acute AAA events and the impact of screening strategies in a population of 92,728 citizens of the United Kingdom. The researchers also utilized population projections to predict acute AAA incidence rates over the coming two decades, and estimate the likely impact of current and potential alternative screening programs.

The results showed that over a 12-year period (2002–2014), 103 acute AAA events occurred in the study population, representing an incidence rate of 9 per 1,000,000. Nearly 73% of the acute AAA events were in males, with 66% of all events occurring over 75 years of age. After extrapolating the results to the overall population, the researchers concluded that current United Kingdom screening program would prevent 10.7% of incident events, 5.6% of aneurysm-related deaths, and 12% of life years lost due to AAA. An alternative strategy of screening men who smoked at age 65, and then all men again (along with women) at 75 would be much more effective, they suggested.

If such a screening policy would be implemented, it would result in a three- to fourfold increase in the proportion of deaths prevented and reduction in life years lost, owing to the much higher incidence of acute AAA events at ages 75–84, and the higher case fatality at older ages. Another alternative screening strategy, based on patient risk factors, could also prevent more deaths and save more life years over the current model, while also decreasing the number of scans required each year. The study was published on August 19, 2015, in the Journal of the American Heart Association (JAHA).

“Given that two thirds of acute AAA occurred at over 75 years of age, screening older age groups should be considered. Screening nonsmokers at age 65 is likely to have very little impact on AAA event rates,” concluded lead author Dominic Howard, PhD, and colleagues. “If the national UK screening policy was modified, this could result in an almost four-fold increase in the number of deaths prevented, and a three-fold increase in the number of life-years saved compared to the current U.K. strategy.”

An AAA is a localized dilatation of the abdominal aorta exceeding the normal diameter by more than 50%, and is the most common form of aortic aneurysm; approximately 90% occur below the kidneys. The aneurysms can extend to include one or both of the pelvic iliac arteries. The major complication of AAA is rupture, which is life-threatening, as large amounts of blood spill into the abdominal cavity, and can lead to death within minutes.]Mortality of rupture repair in the hospital is 60–90%.

Related Links:

John Radcliffe Hospital
Oxford University



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ureteral Dilatation Balloon
Dornier Equinox
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.